Craneware plc (CRWRF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Craneware plc (CRWRF) with AI Score 50/100 (Hold). Craneware plc provides computer software solutions for the healthcare industry in the United States, focusing on pricing transparency and revenue cycle management. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Craneware plc (CRWRF) Healthcare & Pipeline Overview
Craneware plc delivers software solutions to enhance financial performance and operational efficiency for US healthcare providers, specializing in pricing transparency, revenue cycle management, and compliance. With a focus on data analytics and automation, Craneware addresses the complexities of healthcare finance, positioning itself as a key player in the healthcare information services sector.
Investment Thesis
Craneware plc presents a compelling investment case based on its established position in the healthcare information services market and its comprehensive suite of software solutions. The company's focus on pricing transparency, revenue cycle management, and regulatory compliance addresses critical needs for US healthcare providers. With a gross margin of 78.0% and a profit margin of 10.6%, Craneware demonstrates strong profitability. Key growth catalysts include the increasing complexity of healthcare finance and the growing demand for data-driven solutions. The company's beta of -0.36 suggests lower volatility compared to the market. However, investors may want to evaluate the risks associated with operating in a highly regulated industry and the potential for increased competition.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.85 billion indicates a significant presence in the healthcare information services market.
- P/E ratio of 28.49 suggests a premium valuation, reflecting investor expectations for future growth.
- Gross margin of 78.0% demonstrates strong pricing power and efficient cost management.
- Profit margin of 10.6% indicates solid profitability in the competitive healthcare software market.
- Dividend yield of 2.32% provides a steady income stream for investors.
Competitors & Peers
Strengths
- Comprehensive suite of software solutions for healthcare providers.
- Strong focus on pricing transparency and revenue cycle management.
- Established customer base in the US healthcare market.
- Deep expertise in healthcare regulations and compliance.
Weaknesses
- Reliance on the US healthcare market.
- Potential for increased competition from larger technology companies.
- Exposure to changes in healthcare regulations and reimbursement policies.
- Limited brand recognition outside of the US.
Catalysts
- Ongoing: Continued adoption of value-based care models driving demand for Craneware's solutions.
- Ongoing: Increasing complexity of healthcare regulations requiring advanced software solutions.
- Upcoming: Potential acquisitions of complementary technologies to expand product portfolio.
- Ongoing: Expansion of cloud-based offerings to meet evolving customer needs.
- Upcoming: New product launches targeting emerging healthcare challenges in Q3 2026.
Risks
- Potential: Changes in healthcare regulations and reimbursement policies impacting demand for Craneware's solutions.
- Potential: Increased competition from larger technology companies entering the healthcare market.
- Potential: Cybersecurity threats and data breaches compromising sensitive patient information.
- Ongoing: Reliance on the US healthcare market exposing Craneware to economic and political risks.
- Potential: Integration challenges associated with future acquisitions.
Growth Opportunities
- Expansion of Trisus Platform: Craneware can expand its Trisus platform by integrating new modules and functionalities, such as advanced analytics and artificial intelligence, to provide more comprehensive solutions for healthcare providers. The market for AI in healthcare is projected to reach $34 billion by 2025, presenting a significant opportunity for Craneware to enhance its offerings and attract new customers.
- Strategic Acquisitions: Craneware can pursue strategic acquisitions to expand its product portfolio and market reach. Acquiring companies with complementary technologies or customer bases can accelerate growth and strengthen Craneware's competitive position. The healthcare IT market is highly fragmented, offering numerous acquisition opportunities for Craneware to consolidate its presence.
- Increased Focus on Cloud-Based Solutions: Craneware can capitalize on the growing demand for cloud-based solutions by migrating its existing software to the cloud and developing new cloud-native applications. Cloud-based solutions offer greater scalability, flexibility, and cost-effectiveness, making them increasingly attractive to healthcare providers. The global healthcare cloud computing market is expected to reach $55.6 billion by 2027.
- Penetration of Smaller Healthcare Providers: Craneware can target smaller healthcare providers, such as community hospitals and physician practices, which may have limited access to advanced software solutions. By offering tailored solutions and flexible pricing models, Craneware can expand its customer base and increase its market share. The market for healthcare IT solutions among small and medium-sized providers is estimated to be worth $15 billion.
- International Expansion: Craneware can explore opportunities to expand its operations into international markets, such as Europe and Asia, where there is a growing demand for healthcare IT solutions. By adapting its software to meet local regulations and market needs, Craneware can tap into new revenue streams and diversify its geographic footprint. The global healthcare IT market is projected to reach $390 billion by 2024.
Opportunities
- Expansion into new geographic markets.
- Development of new software solutions for emerging healthcare needs.
- Strategic acquisitions to expand product portfolio and market reach.
- Increased adoption of cloud-based solutions in the healthcare industry.
Threats
- Changes in healthcare regulations and reimbursement policies.
- Increased competition from larger technology companies.
- Cybersecurity threats and data breaches.
- Economic downturn and reduced healthcare spending.
Competitive Advantages
- Proprietary technology: Craneware's software solutions are based on proprietary technology and algorithms.
- Established customer base: The company has a large and established customer base in the US healthcare market.
- Regulatory expertise: Craneware possesses deep expertise in healthcare regulations and compliance.
- Data analytics capabilities: The company's solutions leverage data analytics to provide valuable insights to its customers.
About CRWRF
Craneware plc, established in 1999 and headquartered in Edinburgh, UK, develops, licenses, and supports computer software for the healthcare industry in the United States. The company's suite of solutions is designed to improve financial performance, ensure regulatory compliance, and enhance operational efficiency for healthcare providers. Craneware's offerings include Trisus pricing transparency software, which provides tools for price modeling and analysis; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, which assists with medical necessity compliance; and Trisus Claims Informatics, a retrospective charge capture analytical application. Further solutions include Trisus Supply, aimed at improving supplies reimbursement, and InSight Audit, an audit management solution. Craneware also offers InSight Denials for denial data analysis, Trisus Healthcare Intelligence for patient-level resource consumption insights, Trisus Medication Analytic solutions, and Trisus supplies assistant solutions. Additionally, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution for expanding medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution for pharmacy procurement and compliance. Craneware's comprehensive portfolio addresses critical needs in healthcare finance and operations, solidifying its position as a key player in the healthcare information services market.
What They Do
- Develops and licenses computer software for the healthcare industry.
- Provides solutions for pricing transparency and revenue cycle management.
- Offers automated chargemaster management solutions.
- Delivers medical necessity compliance solutions.
- Provides retrospective charge capture analytical applications.
- Offers drug tracking and medication access solutions.
- Provides solutions for pharmacy procurement, utilization, and compliance.
Business Model
- Software licensing: Generates revenue through licensing its software solutions to healthcare providers.
- Subscription services: Offers subscription-based access to its cloud-based solutions.
- Professional services: Provides consulting, implementation, and training services to its customers.
- Maintenance and support: Generates recurring revenue through maintenance and support contracts.
Industry Context
Craneware plc operates within the healthcare information services industry, a sector experiencing significant growth due to increasing regulatory complexity and the need for data-driven decision-making. The market is characterized by a mix of established players and emerging technology companies. Craneware's focus on pricing transparency and revenue cycle management positions it to capitalize on the growing demand for solutions that improve financial performance and compliance for healthcare providers. The industry is expected to continue growing as healthcare organizations seek to optimize operations and navigate evolving regulations.
Key Customers
- Hospitals and healthcare systems: Provides solutions to improve financial performance and compliance.
- Physician practices: Offers software to streamline revenue cycle management.
- Government and commercial payors: Delivers audit management and claims analysis solutions.
Financials
Chart & Info
Craneware plc (CRWRF) stock price: Price data unavailable
Latest News
-
Craneware plc (CRWRF) Q2 2026 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Mar 6, 2026
-
The Craneware Group Named 2026 Best in KLAS® for Trisus® Chargemaster
Yahoo! Finance: CRWRF News · Feb 4, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CRWRF.
Price Targets
Wall Street price target analysis for CRWRF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CRWRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Keith Neilson
CEO
Keith Neilson is the CEO of Craneware plc. His background includes extensive experience in the healthcare technology sector. He has been instrumental in guiding Craneware's strategic direction and growth. Neilson's expertise spans software development, sales, and marketing within the healthcare IT landscape. His leadership is focused on driving innovation and delivering value to Craneware's customers through advanced software solutions.
Track Record: Under Keith Neilson's leadership, Craneware has expanded its product portfolio and strengthened its position in the US healthcare market. Key achievements include the development and launch of the Trisus platform and the acquisition of key technologies to enhance Craneware's offerings. He has overseen the company's growth in revenue and profitability, solidifying its reputation as a leading provider of healthcare financial software.
CRWRF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for trading on OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, and there is no minimum financial standard required. This tier often includes shell companies, defunct companies, and companies with questionable business practices. Investing in OTC Other securities carries a significantly higher risk compared to securities traded on regulated exchanges like the NYSE or NASDAQ due to the lack of transparency and regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in CRWRF.
- Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Lack of regulatory oversight increases the risk of fraud and manipulation.
- The OTC Other tier is associated with higher levels of risk compared to regulated exchanges.
- Potential for limited or no information about the company's operations and financial condition.
- Verify the company's legal status and registration.
- Attempt to obtain and review any available financial statements.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and risk management practices.
- Understand the risks associated with investing in OTC Other securities.
- Consult with a qualified financial advisor before making any investment decisions.
- Craneware plc is an established company with a history of operations.
- The company has a market capitalization of $0.85 billion, suggesting a significant presence in the healthcare information services market.
- Craneware has a dividend yield of 2.32%, indicating a commitment to returning value to shareholders.
Common Questions About CRWRF
What does Craneware plc do?
Craneware plc develops and provides computer software solutions for the healthcare industry, primarily in the United States. Their offerings focus on improving financial performance and operational efficiency for healthcare providers. This includes solutions for pricing transparency, revenue cycle management, chargemaster management, medical necessity compliance, and claims analytics. By automating and streamlining these processes, Craneware helps healthcare organizations optimize their revenue, reduce costs, and ensure compliance with complex regulations, ultimately improving their financial health.
What do analysts say about CRWRF stock?
Analyst consensus on CRWRF stock is currently unavailable due to limited coverage. However, key valuation metrics such as the P/E ratio of 28.49 and the dividend yield of 2.32% provide insights into investor expectations and potential returns. Growth considerations include the company's expansion strategies, product development pipeline, and competitive landscape. Investors should conduct their own due diligence and consider their individual risk tolerance before making any investment decisions.
What are the main risks for CRWRF?
The main risks for Craneware plc include changes in healthcare regulations and reimbursement policies, which could impact demand for its solutions. Increased competition from larger technology companies and cybersecurity threats also pose significant risks. Additionally, the company's reliance on the US healthcare market exposes it to economic and political uncertainties. Potential integration challenges associated with future acquisitions could also affect its growth and profitability. Investors should carefully consider these risks before investing in CRWRF.
What are the key factors to evaluate for CRWRF?
Craneware plc (CRWRF) currently holds an AI score of 50/100, indicating moderate score. Key strength: Comprehensive suite of software solutions for healthcare providers.. Primary risk to monitor: Potential: Changes in healthcare regulations and reimbursement policies impacting demand for Craneware's solutions.. This is not financial advice.
How frequently does CRWRF data refresh on this page?
CRWRF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CRWRF's recent stock price performance?
Recent price movement in Craneware plc (CRWRF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive suite of software solutions for healthcare providers.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CRWRF overvalued or undervalued right now?
Determining whether Craneware plc (CRWRF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CRWRF?
Before investing in Craneware plc (CRWRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for CRWRF
- OTC market data may have limited reliability.